糖尿病预防计划结局研究中新发与非新发糖尿病参与者的肝脏脂肪
本研究在糖尿病预防计划(DPP)随机化约14年后,对1876名参与者用肝脏CT衰减值(LA)评估肝脏脂肪。随访时,糖尿病患者的LA更低(46±16 vs 51±14 HU,P<0.001),脂肪肝患病率更高(34% vs 17%,P<0.001);治疗组间无差异。年均空腹胰岛素、腰围和甘油三酯独立关联LA<40 HU。
要点
- 糖尿病早期肝脏脂肪变常见,糖尿病患者LA更低、脂肪肝患病率更高。
- 生活方式或二甲双胍干预在14年后未显示肝脏脂肪差异。
- 胰岛素抵抗、腰围和甘油三酯与肝脏脂肪变独立相关。
核心结论
- 脂肪肝在糖尿病发展早期常见。
- LA与胰岛素抵抗、腰围和甘油三酯的关联提示这些标志物对该人群肝脂肪变的重要性。
- 早期糖尿病发展阶段的肝脏脂肪评估是必要的。
研究设计与样本
- 在DPP随机化约14年后,对1876名参与者测量肝脏CT衰减值(LA,单位HU)。
- DPP测试了生活方式或二甲双胍干预与标准护理预防糖尿病的效果。
- 比较干预组间及有无糖尿病者的LA,并评估与基线及随访人体测量和代谢协变量的关联。
主要发现
- 随访14年时,各治疗组间肝脏脂肪无差异。
- 糖尿病患者LA更低(均值±SD:46±16 vs 51±14 HU;P<0.001)。
- 糖尿病患者脂肪肝(LA<40 HU)患病率更高(34% vs 17%;P<0.001)。
- LA评估时代谢异常严重程度与更低LA分类呈分级关联,在糖尿病患者中更强。
关键数值与推荐
- 年均空腹胰岛素(胰岛素抵抗指数)与LA<40 HU的OR为1.76(95%CI 1.41-2.20)。
- 年均腰围与LA<40 HU的OR为1.63(95%CI 1.17-2.26)。
- 年均甘油三酯与LA<40 HU的OR为1.42(95%CI 1.13-1.78)。
- 年均空腹血糖与LA<40 HU无独立关联。
临床怎么用
- 在糖尿病早期发展阶段,应考虑评估肝脏脂肪。
- 关注胰岛素抵抗、腰围和甘油三酯水平以识别肝脂肪变高风险者。
- 预防糖尿病的干预措施在14年后未显示对肝脏脂肪的差异影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: There is little information about fatty liver in prediabetes as it transitions to early diabetes. OBJECTIVE: This study is aimed at evaluating the prevalence and determinants of fatty liver in the Diabetes Prevention Program (DPP). METHODS: We measured liver fat as liver attenuation (LA) in Hounsfield units (HU) in 1876 participants at ~14 years following randomization into the DPP, which tested the effects of lifestyle or metformin interventions versus standard care to prevent diabetes. LA was compared among intervention groups and in those with versus without diabetes, and associations with baseline and follow-up measurements of anthropometric and metabolic covariates were assessed. RESULTS: There were no differences in liver fat between treatment groups at 14 years of follow-up. Participants with diabetes had lower LA (mean ± SD: 46 ± 16 vs 51 ± 14 HU; P < 0.001) and a greater prevalence of fatty liver (LA < 40 HU) (34% vs 17%; P < 0.001). Severity of metabolic abnormalities at the time of LA evaluation was associated with lower LA categories in a graded manner and more strongly in those with diabetes. Averaged annual fasting insulin (an index of insulin resistance [OR, 95% CI 1.76, 1.41-2.20]) waist circumference (1.63, 1.17-2.26), and triglyceride (1.42, 1.13-1.78), but not glucose, were independently associated with LA < 40 HU prevalence. CONCLUSION: Fatty liver is common in the early phases of diabetes development. The association of LA with insulin resistance, waist circumference, and triglyceride levels emphasizes the importance of these markers for hepatic steatosis in this population and that assessment of hepatic fat in early diabetes development is warranted.
引用
- Goldberg RB, Tripputi MT, Boyko EJ, et al. Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study. J Clin Endocrinol Metab. 2021. PMID: 33705543. doi:10.1210/clinem/dgab160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。